EUDA Health announces amendment to Streeterville warrant agreement

EUDA Health (EUDA) announced that it has entered into an amendment to its previously disclosed warrant agreement with Streeterville Capital. On December 16, 2025, EUDA and Streeterville Capital entered into the Warrant Amendment to (i) reduce the exercise price of the Warrant from $6.00 per share to $4.00 per share and (ii) reduce the minimum closing price required to trigger a “Forced Exercise” from $7.50 to $6.00. All other terms of the warrant remain unchanged.